Delivery Order SPE2DR25D1205-SPE2DR26F0WF0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,964.91 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on September 3, 2025, with completion targeted for September 4, 2025. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,054.25 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8-count package) on October 22, 2025, with completion targeted for October 23, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999.999 billion and runs through December 2026. The product...
- The Defense Logistics Agency awarded a $1,918.21 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18 count) on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed price contract, performed at AmerisourceBergen's Conshohocken, Pennsylvania location, represents a competitively awarded non-set-aside delivery order. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,563.86 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (18-count units). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,793.12 to AmerisourceBergen Drug Corp on September 22, 2025, for Yuvafem 10 mcg vaginal inserts (18-count). This competitively awarded, firm fixed-price delivery order is classified as non-set-aside and requires completion by September 23, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $4,535.52 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 count) on September 4, 2025, with completion targeted for September 5, 2025. This firm fixed price delivery order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $3,946.09 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 21, 2025. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,467.14 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for Yuvafem 10 mcg vaginal inserts (18 count). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award carries no set-aside designation and is scheduled for completion by October 29, 2025, with performance at AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Yuvafem 10 mcg Vaginal Insert (8-count packages) with a contract ceiling value of $8,089.78. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The order is scheduled for ultimate completion on October 21, 2025, with performance occurring at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18-count units) at a firm fixed price of $1,477.02. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0WF0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,543.42 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 units) on November 4, 2025, with completion scheduled for November 5, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen fulfills the Defense Logistics Agency's medical supply requirements across multiple therapeutic domains. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates its established capability to meet Defense Department medical procurement requirements on a competitive basis, consistently delivering specialty medications, brand-name and generic drugs, and specialized medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 11/4/25 |